Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Other Income / Expenses history
Currency unavailable · from the income statement
No Other Income / Expenses data reported for this period type.
Other Income / Expenses vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
VCREVicore Pharma Holding AB | LTM Jun 2026 | SEK 12.95M SEK | +413.0% | — | 973.7% |
| LTM Mar 2026 | $703K USD | -86.0% | +141.5% | 0.6% | |
| LTM Mar 2026 | -$41.98M USD | +6.5% | — | 11.6% | |
| LTM Jun 2026 | -$51.56M USD | -105.9% | — | 4.5% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -39.7% | +141.5% | 8.1% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.